MedCap Toekomstige groei

Future criteriumcontroles 1/6

MedCap zal naar verwachting zijn omzet verhogen met 13.2% per jaar.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Life Sciences winstgroei	50.6%
Inkomstengroei	13.2%
Toekomstig rendement op eigen vermogen	15.0%
Dekking van analisten	Low
Laatst bijgewerkt	04 Nov 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

MedCap AB (publ)'s (STO:MCAP) Earnings Haven't Escaped The Attention Of Investors

Oct 18

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Jun 06

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

May 21

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

May 04

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Jan 22

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Jan 07

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

Dec 22

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Dec 08

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Nov 23

Winst- en omzetgroeiprognoses

OM:MCAP - Toekomstschattingen van analisten en financiële gegevens uit het verleden (SEK Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	2,438	N/A	268	407	1
12/31/2025	2,143	N/A	216	338	1
12/31/2024	1,838	N/A	243	317	1
9/30/2024	1,801	228	251	308	N/A
6/30/2024	1,753	214	244	299	N/A
3/31/2024	1,681	203	219	268	N/A
12/31/2023	1,600	172	189	228	N/A
9/30/2023	1,466	150	77	114	N/A
6/30/2023	1,343	149	61	97	N/A
3/31/2023	1,241	123	47	82	N/A
12/31/2022	1,124	118	41	86	N/A
9/30/2022	1,056	118	100	167	N/A
6/30/2022	1,017	107	78	146	N/A
3/31/2022	967	102	85	156	N/A
12/31/2021	926	97	55	116	N/A
9/30/2021	896	76	77	109	N/A
6/30/2021	869	64	60	90	N/A
3/31/2021	845	67	79	104	N/A
12/31/2020	828	63	91	115	N/A
9/30/2020	802	55	64	88	N/A
6/30/2020	786	53	75	101	N/A
3/31/2020	763	47	38	62	N/A
12/31/2019	757	55	41	71	N/A
9/30/2019	734	43	80	87	N/A
6/30/2019	740	41	70	107	N/A
3/31/2019	727	32	64	103	N/A
12/31/2018	709	24	56	91	N/A
9/30/2018	716	14	19	57	N/A
6/30/2018	689	8	N/A	27	N/A
3/31/2018	660	10	N/A	46	N/A
12/31/2017	617	7	N/A	41	N/A
10/31/2017	779	11	N/A	79	N/A
7/31/2017	802	3	N/A	85	N/A
4/30/2017	853	0	N/A	81	N/A
1/31/2017	901	5	N/A	32	N/A
10/31/2016	897	10	N/A	-18	N/A
7/31/2016	874	19	N/A	-44	N/A
4/30/2016	818	20	N/A	-15	N/A
1/31/2016	817	18	N/A	-60	N/A
10/31/2015	818	17	N/A	-28	N/A
7/31/2015	825	8	N/A	14	N/A
4/30/2015	855	9	N/A	2	N/A
1/31/2015	891	9	N/A	50	N/A
10/31/2014	913	15	N/A	26	N/A
7/31/2014	910	21	N/A	-1	N/A
4/30/2014	827	23	N/A	1	N/A
1/31/2014	651	18	N/A	29	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van MCAP boven de spaarquote ( 1.1% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van MCAP naar verwachting sneller zal groeien dan de markt Swedish

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van MCAP naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: De omzet van MCAP ( 13.2% per jaar) zal naar verwachting sneller groeien dan de markt Swedish ( 0.03% per jaar).

Hoge groei-inkomsten: De omzet van MCAP ( 13.2% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen MCAP zal naar verwachting over 3 jaar laag zijn ( 15 %).

MedCap Toekomstige groei

Future criteriumcontroles 1/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Third quarter 2024 earnings released: EPS: kr3.57 (vs kr2.59 in 3Q 2023)

MedCap AB (publ)'s (STO:MCAP) Earnings Haven't Escaped The Attention Of Investors

Chief Executive Officer recently bought kr265k worth of stock

Second quarter 2024 earnings released: EPS: kr3.84 (vs kr3.16 in 2Q 2023)

MedCap AB (publ) to Report Q2, 2025 Results on Jul 23, 2025

Now 17% undervalued

Now 21% undervalued

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

Now 21% undervalued

MedCap AB (publ) to Report Q1, 2025 Results on Apr 29, 2025

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

First quarter 2024 earnings released: EPS: kr3.78 (vs kr1.68 in 1Q 2023)

MedCap AB (publ), Annual General Meeting, May 06, 2024

MedCap AB (publ) to Report Fiscal Year 2024 Results on Jan 31, 2025

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Full year 2023 earnings released: EPS: kr11.63 (vs kr7.94 in FY 2022)

Investor sentiment improves as stock rises 19%

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

MedCap AB (publ) to Report Q3, 2024 Results on Oct 25, 2024

Third quarter 2023 earnings released: EPS: kr2.59 (vs kr2.47 in 3Q 2022)

MedCap AB (publ) to Report First Half, 2024 Results on Jul 19, 2024

Second quarter 2023 earnings released: EPS: kr3.16 (vs kr1.42 in 2Q 2022)

MedCap AB (publ) (OM:MCAP) signed an agreement to acquire SurgiCube International B.V. for €8 million.

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

MedCap AB (publ) to Report Q1, 2024 Results on May 03, 2024

First quarter 2023 earnings released: EPS: kr1.68 (vs kr1.32 in 1Q 2022)

Full year 2022 earnings released: EPS: kr7.94 (vs kr6.52 in FY 2021)

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: kr2.47 (vs kr1.73 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Now 21% undervalued

Now 21% undervalued

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

High number of new and inexperienced directors

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

MedCap AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

High number of new and inexperienced directors

MedCap AB (publ) to Report Q1, 2023 Results on May 03, 2023

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

MedCap AB (publ) to Report Q4, 2022 Results on Feb 10, 2023

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Investment Manager recently bought kr828k worth of stock

Third quarter 2021 earnings released: EPS kr1.73 (vs kr0.89 in 3Q 2020)

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Second quarter 2021 earnings released: EPS kr1.06 (vs kr1.33 in 2Q 2020)

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Independent Chairman of the Board recently bought kr1.1m worth of stock

Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS kr4.36 (vs kr4.10 in FY 2019)

New 90-day low: kr193

MedCap (STO:MCAP) Could Easily Take On More Debt

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

An unknown buyer acquired 10.1% stake in MedCap AB (publ) (OM:MCAP) from Bure Equity AB (publ) (OM:BURE).

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Market bids up stock over the past week

New 90-day high: kr233

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Revenue and earnings miss expectations

Third quarter 2020 earnings released: EPS kr0.89

New 90-day high: kr227

New 90-day high - kr207